Published in:
01-06-2014 | Case Report
NUT Midline Carcinoma: A Case Report with a Novel Translocation and Review of the Literature
Authors:
Andrew F. Mills, Michael Lanfranchi, Richard O. Wein, Ian Mukand-Cerro, Monika Pilichowska, Janet Cowan, Harprit Bedi
Published in:
Head and Neck Pathology
|
Issue 2/2014
Login to get access
Abstract
NUT midline carcinoma (NMC) is a rare, genetically defined, highly lethal undifferentiated carcinoma occurring in the midline location of the neck, head or mediastinum. We present the case of a 23 year-old otherwise healthy Chinese male immigrant who presented with complaints of sore throat and right sided neck mass. The initial treatment was for likely EBV infection with streptococcal superinfection. Although continued investigation was pursued shortly after initial presentation, the mass had enlarged and become necrotic with significant nodal involvement. The mass was diagnosed as an NMC tumor with a novel three-way translocation t(9;15;19; q34;q13;p13.1). Despite aggressive treatment, the patient’s condition progressed rapidly and he died within 3 months of initial diagnosis. Standard therapeutic interventions have been ineffective in the treatment of NMC. Earlier diagnosis could allow characterization of the natural progression of this entity, and allow more time for intervention or development of novel therapies, potentially related to molecular targets. This continues to require a high index of suspicion and early imaging with cytogenetic and immunohistochemical confirmation.